Table 2 Comparison of characteristics between survivors and non-survivors in the development cohort.
Characteristics | Non-survive group (n = 97) | Survive group (n = 358) | P-value |
|---|---|---|---|
Sex | 0.979 | ||
Male | 63 (64.95%) | 232 (64.80%) | |
Female | 34 (35.05%) | 126 (35.20%) | |
Age(year) | 62.12 ± 18.94 | 61.88 ± 17.47 | 0.906 |
Diabetes | 0.424 | ||
No | 82 (84.54%) | 290 (81.01%) | |
Yes | 15 (15.46%) | 68 (18.99%) | |
Hypertension | 0.818 | ||
No | 63 (64.95%) | 228 (63.69%) | |
Yes | 34 (35.05%) | 130 (36.31%) | |
Tumors | 0.798 | ||
No | 94 (96.91%) | 345 (96.37%) | |
Yes | 3 (3.09%) | 13 (3.63%) | |
APACHE II Score | 29.11 ± 8.67 | 19.86 ± 7.10 | < 0.001 |
SOFA Score | 10.61 ± 4.17 | 7.76 ± 3.72 | < 0.001 |
CRP (mg/L) | 118.92 ± 72.89 | 101.02 ± 69.18 | 0.026 |
PCT (ng/ml) | 17.38 ± 35.30 | 8.53 ± 20.45 | 0.002 |
Lymphocytes (× 109/L) | 1.57 ± 1.49 | 0.93 ± 0.62 | < 0.001 |
Neutrophils (× 109/L) | 13.52 ± 8.25 | 11.92 ± 6.76 | 0.048 |
Fibrinogen (g/L) | 4.65 ± 2.09 | 4.69 ± 1.94 | 0.833 |
D-dimer (mg/L) | 11.91 ± 15.76 | 7.03 ± 6.66 | < 0.001 |
Urea nitrogen (mmol/L) | 17.99 ± 13.00 | 15.17 ± 10.83 | 0.030 |
Total bilirubin (µmol/L) | 39.39 ± 63.17 | 26.56 ± 40.21 | 0.015 |
Albumin (g/L) | 33.12 ± 6.67 | 33.68 ± 6.04 | 0.429 |
Blood glucose (mmol/L) | 13.82 ± 8.22 | 11.04 ± 3.89 | < 0.001 |
Lactate (mmol/L) | 6.92 ± 6.61 | 4.29 ± 13.42 | < 0.001 |
PaCO2 (mmHg) | 51.85 ± 22.12 | 43.70 ± 12.84 | < 0.001 |
PaO2/FiO2 | 218.54 ± 103.84 | 254.93 ± 93.01 | < 0.001 |
ICU MV time (day) | 8.33 ± 11.47 | 7.26 ± 10.10 | 0.369 |
Shock | < 0.001 | ||
No | 9 (9.28%) | 169 (47.21%) | |
Yes | 88 (90.72%) | 189 (52.79%) | |
Glucocorticoids | 1.000 | ||
No | 42 (43.30%) | 155 (43.30%) | |
Yes | 55 (56.70%) | 203 (56.70%) |
